A detailed history of Exane Derivatives transactions in Neogenomics Inc stock. As of the latest transaction made, Exane Derivatives holds 151 shares of NEO stock, worth $2,594. This represents 0.0% of its overall portfolio holdings.

Number of Shares
151
Previous 2,227 93.22%
Holding current value
$2,594
Previous $27,000 96.3%
% of portfolio
0.0%
Previous 0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$7.06 - $13.97 $14,656 - $29,001
-2,076 Reduced 93.22%
151 $1,000
Q1 2022

Apr 22, 2022

SELL
$12.15 - $35.28 $18,625 - $54,084
-1,533 Reduced 40.77%
2,227 $27,000
Q4 2021

Jan 28, 2022

BUY
$30.49 - $48.49 $8,445 - $13,431
277 Added 7.95%
3,760 $128,000
Q3 2021

Oct 26, 2021

SELL
$41.66 - $52.52 $23,996 - $30,251
-576 Reduced 14.19%
3,483 $168,000
Q2 2021

Jul 28, 2021

SELL
$36.62 - $51.69 $48,375 - $68,282
-1,321 Reduced 24.55%
4,059 $183,000
Q1 2021

Apr 30, 2021

SELL
$41.56 - $59.88 $94,465 - $136,107
-2,273 Reduced 29.7%
5,380 $259,000
Q4 2020

Jan 27, 2021

BUY
$36.08 - $56.47 $276,120 - $432,164
7,653 New
7,653 $412,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.16B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.